Mersana Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.24 | $157.41 M | -2.5 | 51 | $0 |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.30 | $120.37 M | -1.65 | 384 | $380.79 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $13.45 | $1.29 B | -7.16 | 85 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.00 | $1.12 B | -5.11 | 174 | $0 |
 HOOK
|
HOOKIPA Pharma Inc. | $2.79 | $79.07 M | -1.71 | 151 | $20.13 M |
 INZY
|
Inozyme Pharma, Inc. | $2.88 | $286.39 M | -3.43 | 59 | $0 |
 KURA
|
Kura Oncology, Inc. | $16.04 | $1.66 B | -10.03 | 142 | $0 |
 MRUS
|
Merus N.V. | $44.28 | $3.50 B | -19.38 | 172 | $43.95 M |
 PLRX
|
Pliant Therapeutics, Inc. | $12.32 | $672.63 M | -3.9 | 166 | $1.58 M |
 PTGX
|
Protagonist Therapeutics, Inc. | $40.43 | $2.04 B | 13.7 | 126 | $60.00 M |
 RCUS
|
Arcus Biosciences, Inc. | $14.43 | $1.41 B | -4.98 | 577 | $117.00 M |
 REPL
|
Replimune Group, Inc. | $10.79 | $485.18 M | -2.44 | 331 | $0 |
 RLAY
|
Relay Therapeutics, Inc. | $4.88 | $1.05 B | -3 | 294 | $25.55 M |
 RVMD
|
Revolution Medicines, Inc. | $54.22 | $6.66 B | -10.51 | 490 | $11.58 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $16.09 | $1.66 B | -6.02 | 184 | $0 |
 TERN
|
Terns Pharmaceuticals, Inc. | $5.69 | $462.44 M | -5.67 | 66 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VRDN
|
Viridian Therapeutics, Inc. | $20.35 | $776.72 M | -2.71 | 94 | $314,000 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.38 | $169.62 M | -1.51 | 127 | $0 |